J Buon
-
Meta Analysis
A meta-analysis of clinical trials over regimens with or without cetuximab for advanced gastric cancer patients.
To evaluate the efficiency and toxicity of treatment with or without cetuximab in patients with advanced gastric cancer (AGC). ⋯ Adding cetuximab to chemotherapy does not improve OS or DCR compared with chemotherapy alone. Cetuximab-containing combination chemotherapy can reduce the risk of neutropenia.